<SEC-DOCUMENT>0000886163-20-000141.txt : 20201221
<SEC-HEADER>0000886163-20-000141.hdr.sgml : 20201221
<ACCEPTANCE-DATETIME>20201221083958
ACCESSION NUMBER:		0000886163-20-000141
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20201218
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201221
DATE AS OF CHANGE:		20201221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		201402510

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lgnd-20201218.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:737cd398-efb4-4266-8d94-e04d4b909781,g:ac3ca876-c5be-40e8-ab59-a68f9c1fee71,d:2bbd9a1b1f1542488a4958d77a8d8efe--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20201218</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV80L2ZyYWc6MWIzNWE3ZGFjNTcxNGMzNGIyZmRkZjVkNzgyODIxNWYvdGFibGU6N2E3NTI2MGM2ZTZkNDMxZDk4ZDkxMDAyYTU4NGJhYmYvdGFibGVyYW5nZTo3YTc1MjYwYzZlNmQ0MzFkOThkOTEwMDJhNTg0YmFiZl8yLTEtMS0xLTA_b6c544ee-ff0d-4e85-b7db-4def99987f29">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV80L2ZyYWc6MWIzNWE3ZGFjNTcxNGMzNGIyZmRkZjVkNzgyODIxNWYvdGFibGU6N2E3NTI2MGM2ZTZkNDMxZDk4ZDkxMDAyYTU4NGJhYmYvdGFibGVyYW5nZTo3YTc1MjYwYzZlNmQ0MzFkOThkOTEwMDJhNTg0YmFiZl8zLTEtMS0xLTA_a7aca8d4-ec99-48f7-8e2d-fed89e19d0bd">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20201218.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-18</xbrli:startDate><xbrli:endDate>2020-12-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2bbd9a1b1f1542488a4958d77a8d8efe_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:173%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:173%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:173%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:173%">______________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:173%">FORM <ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl85Nw_123bfef4-c2e6-4fef-ac55-606fe2b5366a">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:173%">______________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%">Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%">Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:173%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8yNTI_600b3f7a-a5e8-4556-a3d6-4d5f76017dc3">December 18, 2020</ix:nonNumeric> </span></div><div style="margin-bottom:7pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:173%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8yNTY_c1192417-d1ed-450c-a546-5d9145b0037d">LIGAND PHARMACEUTICALS INC</ix:nonNumeric>ORPORATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">     </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.538%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NDUwMDFiMGMzZmI0NDRiZjgzYjYyNDNiODMzMTQ0YmEvdGFibGVyYW5nZTo0NTAwMWIwYzNmYjQ0NGJmODNiNjI0M2I4MzMxNDRiYV8wLTAtMS0xLTA_d75e8d8d-f3fd-4ae4-8d84-03cc988864a3">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NDUwMDFiMGMzZmI0NDRiZjgzYjYyNDNiODMzMTQ0YmEvdGFibGVyYW5nZTo0NTAwMWIwYzNmYjQ0NGJmODNiNjI0M2I4MzMxNDRiYV8wLTEtMS0xLTA_414567cc-aafd-4296-9d67-ff10a9b006ba">001-33093</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NDUwMDFiMGMzZmI0NDRiZjgzYjYyNDNiODMzMTQ0YmEvdGFibGVyYW5nZTo0NTAwMWIwYzNmYjQ0NGJmODNiNjI0M2I4MzMxNDRiYV8wLTItMS0xLTA_95694f12-0733-45e4-b3a6-746eb650418c">77-0160744</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Identification No.)</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.617%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NTZhMDA0ZDRiMTNjNDU0MGI4ZWRkMTY0ODM0MWQ1ZDIvdGFibGVyYW5nZTo1NmEwMDRkNGIxM2M0NTQwYjhlZGQxNjQ4MzQxZDVkMl8wLTAtMS0xLTA_084b8bc8-a4ec-475f-9b55-5dfcec9f1379">3911 Sorrento Valley Boulevard, Suite 110</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NTZhMDA0ZDRiMTNjNDU0MGI4ZWRkMTY0ODM0MWQ1ZDIvdGFibGVyYW5nZTo1NmEwMDRkNGIxM2M0NTQwYjhlZGQxNjQ4MzQxZDVkMl8xLTAtMS0xLTA_cea6e873-a40d-4290-aca9-239f9c3edd23">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NTZhMDA0ZDRiMTNjNDU0MGI4ZWRkMTY0ODM0MWQ1ZDIvdGFibGVyYW5nZTo1NmEwMDRkNGIxM2M0NTQwYjhlZGQxNjQ4MzQxZDVkMl8yLTAtMS0xLTA_e0b496b4-eb84-4286-b5cf-bb07f0cda4fa">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NTZhMDA0ZDRiMTNjNDU0MGI4ZWRkMTY0ODM0MWQ1ZDIvdGFibGVyYW5nZTo1NmEwMDRkNGIxM2M0NTQwYjhlZGQxNjQ4MzQxZDVkMl8yLTItMS0xLTA_2a2734e8-8b8b-4926-94ab-24db7a485012">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8zMzQ_26842337-6919-4023-9683-90d472165c1e">858</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8zMzg_f162d315-2b94-43dd-9391-b688b5afdbcb">550-7500</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:173%">N/A</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl82MzU_c9f3d7f3-0cfa-43da-aeff-b53e900467f1">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl83MjQ_f18980bd-73e1-42e4-a648-3fae5e5b001a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl84MTQ_9522b1a1-65f8-4821-a046-d22f18f9b677">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl85MjA_df408752-7ccf-4e51-a095-12dd50867012">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Ac</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:37.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NzAyNjlkOTAwNTA3NDliM2E3OWVkNjIxYzQ1OWVmNzAvdGFibGVyYW5nZTo3MDI2OWQ5MDA1MDc0OWIzYTc5ZWQ2MjFjNDU5ZWY3MF8xLTAtMS0xLTA_710424b0-d7de-46ec-997c-d79cfa81a561">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NzAyNjlkOTAwNTA3NDliM2E3OWVkNjIxYzQ1OWVmNzAvdGFibGVyYW5nZTo3MDI2OWQ5MDA1MDc0OWIzYTc5ZWQ2MjFjNDU5ZWY3MF8xLTEtMS0xLTA_8aca0a46-790e-48da-8e6b-b6f4c401480c">LGND</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NzAyNjlkOTAwNTA3NDliM2E3OWVkNjIxYzQ1OWVmNzAvdGFibGVyYW5nZTo3MDI2OWQ5MDA1MDc0OWIzYTc5ZWQ2MjFjNDU5ZWY3MF8xLTItMS0xLTA_3f55a870-228a-4269-bdb2-5ae12bff644a">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8xMzU0_6860a5f1-1ed8-4a0c-a13c-751468f641ce">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i2bbd9a1b1f1542488a4958d77a8d8efe_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 8.01     Other Events.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 21, 2020 we issued a press release to report that we and GlaxoSmithKline (GSK) had formed a collaboration which aims to, utilizing our Icagen discovery technology and our unique expertise in small molecule therapeutics targeting transmembrane proteins, identify and develop inhibitors of a specific genetically-validated molecular target relevant to neurological diseases.  The collaboration will be governed by the Research Collaboration, Option and License Agreement dated December 18, 2020 between our subsidiary Icagen, LLC and GSK. </span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9.01     Financial Statements and Exhibits. </span></div><div><span><br/></span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(d)    Exhibits.</span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit No.</span><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                     </span><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"> Description</span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit991_201221gskagreem.htm">99.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit991_201221gskagreem.htm"> </a></span><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                             Press release issued December 21, 2020.</span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> ***</span></div><div><span style="color:#000033;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Form 8-K contains forward-looking statements by Ligand that involve risks and uncertainties and reflect Ligand's judgment as of the date of this release.  Please see the disclaimer and cautions in the &#8220;Forward-Looking Statements&#8221; section of the attached press release.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:20pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:6pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.993%"><tr><td style="width:1.0%"></td><td style="width:40.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: December 21, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:38.25pt;padding-right:2.25pt;text-indent:-33.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Charles S. Berkman         </span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:38.25pt;padding-right:2.25pt;text-indent:-33.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:    Charles S. Berkman</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:38.25pt;padding-right:2.25pt;text-indent:-33.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:    Senior Vice President, General Counsel and Secretary </span></div></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>lgnd-20201218.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:737cd398-efb4-4266-8d94-e04d4b909781,g:ac3ca876-c5be-40e8-ab59-a68f9c1fee71-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20201218" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20201218">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20201218_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20201218_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20201218_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20201218_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.ligand.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>3
<FILENAME>lgnd-20201218_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:737cd398-efb4-4266-8d94-e04d4b909781,g:ac3ca876-c5be-40e8-ab59-a68f9c1fee71-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20201218.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>lgnd-20201218_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:737cd398-efb4-4266-8d94-e04d4b909781,g:ac3ca876-c5be-40e8-ab59-a68f9c1fee71-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20201218.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended" id="icb82a38cb6ad4ddf81050d5c1ec59bb1_CoverPage"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>lgnd-20201218_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:737cd398-efb4-4266-8d94-e04d4b909781,g:ac3ca876-c5be-40e8-ab59-a68f9c1fee71-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_b6303e4b-4f18-4d1e-be9c-ac98a3b0f3e1_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_6487afb6-4113-4746-8c1d-42379ecd6c87_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7ec4e698-10aa-4a77-a36e-cf3d0b0f2ce7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8201ad54-8455-430b-90b4-3a50a9633596_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_9f61a89d-9853-4b2b-b974-653d0da3e357_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0a3ee2c9-873b-4f39-b401-229d71f9d0a0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_29aba3c5-09e2-42ac-9d4a-c84889ba06fd_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e064bf60-9fbf-4621-91d7-32ed62b34d4f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_1aeb097e-5bd9-4d4a-a6ce-ffde1224b792_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6860b63a-f9ae-426d-96b8-b27ce345eef9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_4bcceda9-3a9b-49c1-a322-5c1d67323102_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_345324c2-5941-4112-af9e-48babc6fcd6f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f334fb14-8d70-48cb-b61b-03e070df6fdd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2bc38d11-aba2-4778-836a-94c984f4ae8d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_11701ef6-3c74-4094-a1d2-f0a5704b848f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_41539b25-9b1c-4a39-8636-9d220fa2862e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ecc293de-86f8-4d30-bc13-a3a940b3de3e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9fe19178-495d-4245-af06-858436c24013_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5be96689-a8f5-421f-9703-f2f500d121cb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b03e0f4f-7770-406d-86cd-424113e7e118_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_2833e33e-0901-48ce-a8a6-46a3613fd67b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f436df37-a511-44cd-8dde-4b19683ed1b6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_45dce6bb-d583-4780-bf13-731ab6fc2002_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lgnd-20201218_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:737cd398-efb4-4266-8d94-e04d4b909781,g:ac3ca876-c5be-40e8-ab59-a68f9c1fee71-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20201218.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8cb356eb-cfaf-45e2-80e8-612462fda864" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityCentralIndexKey_8cb356eb-cfaf-45e2-80e8-612462fda864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_535b0eeb-39dc-46d0-a64d-d39051087864" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_AmendmentFlag_535b0eeb-39dc-46d0-a64d-d39051087864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d477ff15-497d-4cb5-a143-5ed3e6ceb62c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_DocumentType_d477ff15-497d-4cb5-a143-5ed3e6ceb62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_01f93e38-9289-4062-9fef-fdc68b75bd30" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_DocumentPeriodEndDate_01f93e38-9289-4062-9fef-fdc68b75bd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_87926024-d105-4584-b603-aff6e2ce3e9f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityRegistrantName_87926024-d105-4584-b603-aff6e2ce3e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4bb1ba89-a2b4-489e-aae0-3b500e9de577" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4bb1ba89-a2b4-489e-aae0-3b500e9de577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bd9c7bf1-7b34-4a05-af20-3be92e6a6a68" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityFileNumber_bd9c7bf1-7b34-4a05-af20-3be92e6a6a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_78c196ce-de9b-404a-9af0-cbd2b7126df1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityTaxIdentificationNumber_78c196ce-de9b-404a-9af0-cbd2b7126df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_419d253b-7d01-4786-bef2-1ed89278c092" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityAddressAddressLine1_419d253b-7d01-4786-bef2-1ed89278c092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_631f58fc-576f-4aaa-816d-8114a4b694a2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityAddressCityOrTown_631f58fc-576f-4aaa-816d-8114a4b694a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f3461c5e-0f18-40f0-9975-addb89401fd4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityAddressStateOrProvince_f3461c5e-0f18-40f0-9975-addb89401fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_aa7f5d62-5363-489f-98a0-052a41bb8815" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityAddressPostalZipCode_aa7f5d62-5363-489f-98a0-052a41bb8815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_895f4a0b-7efd-44e5-a499-661aee39570d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_CityAreaCode_895f4a0b-7efd-44e5-a499-661aee39570d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1826925e-c8a1-4358-9648-bb2d386ee2e6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_LocalPhoneNumber_1826925e-c8a1-4358-9648-bb2d386ee2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_4826b0f7-9c6e-427e-a4f7-3d94a8cdf8b4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_WrittenCommunications_4826b0f7-9c6e-427e-a4f7-3d94a8cdf8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e6f9e8c5-c5d0-4f20-94bd-48d110f93a8b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_SolicitingMaterial_e6f9e8c5-c5d0-4f20-94bd-48d110f93a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_05d36f45-87cf-42f7-8635-3ff9968d5a35" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_PreCommencementTenderOffer_05d36f45-87cf-42f7-8635-3ff9968d5a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_bcc8ae6d-70ea-47d9-a1f3-bf5457326d5c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_bcc8ae6d-70ea-47d9-a1f3-bf5457326d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_08fbfe51-750d-4c06-b1fd-df0d6921a831" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_Security12bTitle_08fbfe51-750d-4c06-b1fd-df0d6921a831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_27febcad-90c1-4541-bc13-cdff442f9067" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_TradingSymbol_27febcad-90c1-4541-bc13-cdff442f9067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f5551b74-23cd-453a-a400-f4eb9ecf86a3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_SecurityExchangeName_f5551b74-23cd-453a-a400-f4eb9ecf86a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e549eb18-5388-4f26-82c9-32dcabd8e0fa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3f1b4fd8-8c12-43ca-a856-475f2526bd01" xlink:to="loc_dei_EntityEmergingGrowthCompany_e549eb18-5388-4f26-82c9-32dcabd8e0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_01.jpg
<TEXT>
begin 644 image_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "? <$# 2(  A$! Q$!_\0
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MI#&] >I?\/XOV8_^B7^//_ "S_\ DFBJ_P#PXP_9Q_Z';XA?^!NG?_&J*/=
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M*&K +115'Q+XF\/^#=!O/%/BO6;?3]-T^W>>^OKN0)%!$BEF=F/   ))/I2
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M:$(J*79122_!'X_BL56QN*J8BL[SG)RD^[D[M_>S],#+&#M,BY'4;J\ZUO\
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M=;^)/CC6?B)XE:-M1U[5KG4K\PQ!$,\\K2R$*/NC>[<=J(@9-?4W[!'_  3
M^('[8-HWQ(\7:Y<>%? \%RL<.H?81)<ZRRR 2QVH8A410'4W#!T$F%"2%9 G
MB_[+GP.N/VDOVA?"7P1CN9(8=>U98]0GAF6.2*S16EN7C+*P\P01R%<@@L%S
MQ7[WZ#HFD^&M#L_#F@:3:V%CI]K';65C90K'#;PHH5(T10 JJH "@  # H;
M^9/!/_!&[]@_PKH$>D:Y\.]6\17"NS-JFM>)KM)WS_"1:R0Q8';" ^I-<W\7
M_P#@B/\ LG^-+*27X77FN^"[[;B#[+J#7UKGY>7CN2TC=&P%E3ESG(  ^RJ*
MD#\%_P!JK]D3XR?L>>/(O _Q9TVWDCO8//T?7--9WL=0C&-XC=E4[XRP5XV"
MLI*M@H\;MY>"0<@U^X'_  4B_9_L?VA/V2?%6C+ITDVK:#ITVM^'S;V;W$YN
M[:-I/*BC1E+/-&)(!UP9@P5BH!_#]3N7=BK0'[(?\$G/VO-6_:=^ LOAKQQJ
M$]WXJ\$O#9:M?7,CO)?6[J?LUR[$8,C".2-_F=F: R-M\T*/JBOQN_X(V>.[
M[P=^W/H^BV-M Z^*=!U'2KJ293F.)8?MN5.1AM]F@Y###,,9((_9&H8'Q3_P
M7<<K^R7X;VGEOB):CIU'V"__ /K5^3\44T[^5!"TC'HJ+DFOWL_:I_97^&7[
M7WPR7X6_%/\ M".T@U**_L;S2KL0W%K<(&4.A970YCDEC(=&&V0D ,%9>9_9
M:_X)\_LV?LG0+J'@3PBVH>(.=_BK7I%N;\ ^8,1ML5+<;)6C/DHA= N\N1FJ
MN!^;?[.7_!(W]K#XY^3J_BS0$\":+),OF77B>-H[SRQ*R2E+,?O=Z[20LWDJ
MX*E7(.:^H?!/_!!;X)66F-#\1_C7XLU2\:8E;C0X;73XTCQP-DL=R68'/.X
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M?^#?YRR?%A!_"VAGZY_M#_"OT;K\X_\ @W\_YJU_W ?_ '(U^CE3+<#\3/\
M@JO_ ,G^_$+_ *^;#_TW6M?/5?0O_!5?_D_WXA?]?-A_Z;K6OGJK _=+_@GY
M\,O!/PQ_8^^']OX*T&&Q_MCPKI^KZH\:_-=7ES:Q2S3.>K,6.!GHJJHPJJ![
M-7G'['7_ ":-\+/^R<Z)_P"D$->CUF 4444 5]7TS3]:TJZT;5].AO+2[MWA
MNK6ZC#QS1LI5D=2"&4@D$$$$&OYW_%?A;6/ WBG4_!/B*W\G4-'U&>ROHO,5
M]DT4C(Z[EX;#*>1P:_HH8;E*YZ^E?@5^UU;Q6G[5_P 3[2!=L<7Q$UM$7.<
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MC\*6D@DD\.^';/3YYK:+8DTL4*H\@&!]YPS9(!);)Y)KL*^>O^"9G[1GP_\
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M (JO;/\ ATI_P4(_Z-]_\NS2?_DJC_ATI_P4(_Z-]_\ +LTG_P"2J+@>)_\
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MA_1[>184>1HFVJ7<XWNQ),CM\SL6=LDM7XZZW^Q+^V%H.JS:1>?LO^/9)86
M=K/PK<W,?(SQ)"CQMP?X6.#QVHY@/LS_ (-_/^:M?]P'_P!R-?HY7Q'_ ,$8
M/V7?C;^S_P"$/&7C#XP>#I-!7Q<VF_V7IM\VV\5+=;@M)+%C,08W(4*Y$F8V
MW(H*EOMRI>X'XF?\%5_^3_?B%_U\V'_INM:^>J^U?^"HG[%W[4GB']K#Q1\8
M?"'P5UK7_#_B"ZM!IEYX=M3?2,4L8(W#PP[I8L-&PW,@4\8)S7@7A7]A/]LG
MQCK4>@Z5^S'XVAGE^X^J>'YK&'KCF6Y6.->3W88&3V-4!^S/['7_ ":-\+/^
MR<Z)_P"D$->CUQ_[//@K7/AK\ O _P .?$RQ#4O#_A'3=-U#[/)OC\Z"UCB?
M:V!E=RG!P,BNPJ "BBB@ K\#?VPO^3N/BG_V4?7/_3A/7[Y,2%R!GV]:_&/]
MM/\ 8=_:YLOVE/&GB^S_ &>_%&J:;XF\7:KJ>D7F@Z:=262WENY)$+_93(83
MM=?ED"MUXXJH@?,=?T<5^%OPX_X)[?MG?$WQ%#X=TK]GCQ-IADE19;WQ)I4N
MFV\*D\NSW"KD* 20@9N, $D _NE1( KY$_X*R?L.7O[37PSMOBE\.+,'QAX/
MMYG6U@MPTFL6)!=K;Y4,CR(V7A4'&YY5"EI0R_7=! 8;2*D#^<<@JQ5ARIPP
M]#3HY'B=9$.&5LJ?2OUZ_;A_X),_"_\ :8U"?XD?"S4;;P;XND\Z6\-OIZFQ
MU>5O,DWW")M9)GE92UPNX[2Y:.1BI7\[?BW_ ,$[_P!LKX,ZV-%\1? C7-46
M1G^SZAX5LI-4MI55]N_=;JS1@Y! E6-B#G:,'%W [#X*?\%;OVS?@SIC:--X
MQL?%UJL86WC\96KW4D?))8SQR1SR$Y_Y:2/C  Q6Y\0O^"U/[:WC;1X]*T.Y
M\*^%76;?)>^']!9YI%VL/+/VR6= N2#E5#9488#(/R2C+(N^,[ESC<O2NA\
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M%0R;2461G7\<M3TO5=#U.XT37=,N+&^L[AX+VRNX6CEMYD8J\;HP#*RL""I
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>exhibit991_201221gskagreem.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i1f1db2767ad7421e86c359e323962663_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-indent:18pt"><font><br></font></div><div><img alt="image_01.jpg" src="image_01.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:196px"></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen&#8217;s Discovery Technology to Target Neurological Disorders</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:111%">Ligand Group is eligible to receive an upfront payment of $7 million and potential milestone payments and fees of up to $154.5 million and tiered royalties</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SAN DIEGO (December 21, 2020) &#8211; Ligand Pharmaceuticals Incorporated (NASDAQ&#58; LGND)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> announced today a collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline (GSK) to leverage Icagen&#8217;s unique expertise in small molecule therapeutics targeting transmembrane proteins.  This collaboration will utilize the Icagen discovery technology to identify and develop inhibitors of a specific genetically-validated molecular target relevant to neurological diseases.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;We are very pleased to partner with a global pharmaceutical company like GSK with an ambitious innovation agenda,&#8221; said Matt Foehr, President and COO of Ligand.&#160; &#8220;This agreement fits perfectly within the Ligand strategy to establish and leverage partnerships with industry leaders as they access our technologies and expertise for their drug-discovery needs.&#160; GSK has also recognized that great ideas come from relationships like this one and they have a history of successfully working with others to access innovation and deliver next-generation transformational medicines.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Central to GSK&#8217;s innovation agenda is working with cutting-edge partners to help us develop genetically-validated, transformational medicines in ways that are faster and more effective,&#8221; said John Lepore, Senior Vice President, Research, GSK.  &#8220;Ligand&#8217;s unique model systems and depth of expertise will enable our team to advance this drug-discovery program with a higher probability of success and may help deliver a new treatment option for patients suffering from neurological disease.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the terms of the collaboration and license agreement, Ligand will receive an upfront payment of $7 million.  Ligand could receive additional development, regulatory and commercialization milestone payments, conditional on meeting those milestones, of up to $154.5 million.  Ligand will receive tiered royalties on net sales of any drug from the collaboration that is commercialized by GSK.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ligand will be responsible for most preclinical activities up to lead optimization, with Ligand and GSK collaborating to identify candidates for entry into IND-enabling studies.  GSK has the exclusive option to license any identified inhibitors and will be responsible for the further development and commercialization of any drug candidates identified through the collaboration.  Ligand acquired Icagen in April 2020, adding enabling technologies to its business offering that will support this collaborative drug-discovery program.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Icagen Technology Platform </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Icagen Technology Platform is focused primarily on ion channel and transporter novel drug discovery.  Ion channels and transporters are key components in a wide variety of biological processes that involve rapid changes in cells and have broad therapeutic applicability including cancer, metabolic disease, pain, neurological diseases, infectious diseases and others.  The Icagen Technology Platform leverages proprietary expertise in the combination of biological assays, medicinal chemistry,&#160;and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">in silico</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and computational chemistry applications.&#160; Partners in the pharmaceutical industry leverage our platform to develop first-in-class therapies for patients in need, typically under arrangements in which we work closely through the time of clinical candidate selection, with our partners responsible for clinical development and commercialization. For more information, please visit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.ligand.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#160; </font></div><div style="text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Ligand Pharmaceuticals</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand&#8217;s business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure.  Ligand&#8217;s goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company.  Ligand&#8217;s business model is based on doing what Ligand does best&#58; drug discovery, early-stage drug development, product reformulation and partnering.  Ligand partners with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue.  Ligand&#8217;s OmniAb</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> technology platform is a patent-protected transgenic animal platform used in the discovery of fully human mono- and bispecific therapeutic antibodies.  The Captisol</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs.  Ligand&#8217;s Protein Expression Technology</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> is a robust, validated, cost-effective and scalable approach to recombinant protein production, and is especially well-suited for complex, large-scale protein production that cannot be made by more traditional systems.  Ab Initio&#8482; technology and services for the design and preparation of customized antigens enable the successful discovery of therapeutic antibodies against difficult-to-access cellular targets.  Ligand has established multiple alliances, licenses and other business relationships with the world&#8217;s leading pharmaceutical companies including Amgen, Merck, Pfizer, Roche, Sanofi, Janssen, Takeda, Gilead Sciences, GSK and Baxter International.  For more information, please visit www.ligand.com. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Follow Ligand on Twitter &#64;Ligand_LGND.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">This news release contains forward-looking statements by Ligand that involve risks and uncertainties and reflect Ligand's judgment as of the date of this release.  Words such as &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; and &#8220;will,&#8221; and similar expressions, are intended to identify forward-looking statements.  These forward-looking statements include, without limitation, statements regarding the potential benefits of the Ligand Group&#47;GSK collaboration agreement program.  Actual events or results may differ from Ligand's expectations due to risks and uncertainties inherent in Ligand&#8217;s business, including, without limitation&#58; there can be no assurance that the GSK program with Ligand will be able to successfully identify any desirable drug candidates or that any drug candidates developed in such programs would be clinically or commercially successful, all of which might result in the potential license option exercise fee, milestone payments and royalties not being earned&#59; Ligand may not receive expected revenue from royalties, Captisol sales, contract and service revenue&#59; the COVID-19 pandemic has disrupted Ligand&#8217;s and its partners&#8217; business, including delaying manufacturing, pre-clinical studies and clinical trials and product sales, and impairing global economic activity, all of which could materially and adversely impact Ligand&#8217;s results of operations and financial condition&#59; effective COVID-19 vaccines may limit the market for Captisol-enabled remdesivir&#59; Ligand and its partners may not be able to timely or successfully advance any product(s) in its internal or partnered pipeline&#59; Ligand may not achieve its guidance for 2020&#59; development of product candidates by Ligand partners may not be successful&#59; Ligand may not be able to create future revenues and cash flows by developing innovative therapeutics&#59; results of any clinical study may not be timely, favorable or confirmed by later studies&#59; products under development by Ligand or its partners may not receive regulatory approval&#59; there may not be a market for the product(s) even if successfully developed and approved&#59; Ligand or its partners may not be able to protect their intellectual property and patents covering certain products and technologies may be challenged or invalidated&#59; Ligand's partners may terminate any of its agreements or development or commercialization of any of its products&#59; Ligand may not generate expected revenues under its existing license agreements&#59; Ligand and its partners may experience delays in the commencement, enrollment, completion or analysis of clinical testing for its product candidates, or significant issues regarding the adequacy of its clinical trial designs or the execution of its clinical trials, which could result in increased costs and delays, or limit Ligand's ability to obtain regulatory approval&#59; unexpected adverse side effects or inadequate therapeutic efficacy of Ligand's product(s) could delay or prevent regulatory approval or commercialization&#59; Ligand may not be able to successfully implement its strategic growth plan and continue the development of its proprietary programs&#59; and ongoing or future litigation could expose Ligand to significant liabilities and have a material adverse effect on the company.  The failure to meet expectations with respect to any of the foregoing matters may reduce Ligand's stock price.  Additional information concerning these and other risk factors affecting Ligand can be found in prior press releases available at www.ligand.com as well as in Ligand's public periodic filings with the Securities and Exchange </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Commission available at www.sec.gov.  Ligand disclaims any intent or obligation to update these forward-looking statements beyond the date of this release.  This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contacts&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ligand Pharmaceuticals Incorporated&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;LHA Investor Relations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Patrick O&#8217;Brien&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Bruce Voss</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">investors&#64;ligand.com&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;bvoss&#64;lhai.com&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(858) 550-7893&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(310) 691-7100</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Twitter&#58; &#64;Ligand_LGND</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">#   #   #</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>lgnd-20201218_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lgnd-20201218.xsd" xlink:type="simple"/>
    <context id="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-12-18</startDate>
            <endDate>2020-12-18</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV80L2ZyYWc6MWIzNWE3ZGFjNTcxNGMzNGIyZmRkZjVkNzgyODIxNWYvdGFibGU6N2E3NTI2MGM2ZTZkNDMxZDk4ZDkxMDAyYTU4NGJhYmYvdGFibGVyYW5nZTo3YTc1MjYwYzZlNmQ0MzFkOThkOTEwMDJhNTg0YmFiZl8yLTEtMS0xLTA_b6c544ee-ff0d-4e85-b7db-4def99987f29">0000886163</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV80L2ZyYWc6MWIzNWE3ZGFjNTcxNGMzNGIyZmRkZjVkNzgyODIxNWYvdGFibGU6N2E3NTI2MGM2ZTZkNDMxZDk4ZDkxMDAyYTU4NGJhYmYvdGFibGVyYW5nZTo3YTc1MjYwYzZlNmQ0MzFkOThkOTEwMDJhNTg0YmFiZl8zLTEtMS0xLTA_a7aca8d4-ec99-48f7-8e2d-fed89e19d0bd">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl85Nw_123bfef4-c2e6-4fef-ac55-606fe2b5366a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8yNTI_600b3f7a-a5e8-4556-a3d6-4d5f76017dc3">2020-12-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8yNTY_c1192417-d1ed-450c-a546-5d9145b0037d">LIGAND PHARMACEUTICALS INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NDUwMDFiMGMzZmI0NDRiZjgzYjYyNDNiODMzMTQ0YmEvdGFibGVyYW5nZTo0NTAwMWIwYzNmYjQ0NGJmODNiNjI0M2I4MzMxNDRiYV8wLTAtMS0xLTA_d75e8d8d-f3fd-4ae4-8d84-03cc988864a3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NDUwMDFiMGMzZmI0NDRiZjgzYjYyNDNiODMzMTQ0YmEvdGFibGVyYW5nZTo0NTAwMWIwYzNmYjQ0NGJmODNiNjI0M2I4MzMxNDRiYV8wLTEtMS0xLTA_414567cc-aafd-4296-9d67-ff10a9b006ba">001-33093</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NDUwMDFiMGMzZmI0NDRiZjgzYjYyNDNiODMzMTQ0YmEvdGFibGVyYW5nZTo0NTAwMWIwYzNmYjQ0NGJmODNiNjI0M2I4MzMxNDRiYV8wLTItMS0xLTA_95694f12-0733-45e4-b3a6-746eb650418c">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NTZhMDA0ZDRiMTNjNDU0MGI4ZWRkMTY0ODM0MWQ1ZDIvdGFibGVyYW5nZTo1NmEwMDRkNGIxM2M0NTQwYjhlZGQxNjQ4MzQxZDVkMl8wLTAtMS0xLTA_084b8bc8-a4ec-475f-9b55-5dfcec9f1379">3911 Sorrento Valley Boulevard, Suite 110</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NTZhMDA0ZDRiMTNjNDU0MGI4ZWRkMTY0ODM0MWQ1ZDIvdGFibGVyYW5nZTo1NmEwMDRkNGIxM2M0NTQwYjhlZGQxNjQ4MzQxZDVkMl8xLTAtMS0xLTA_cea6e873-a40d-4290-aca9-239f9c3edd23">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NTZhMDA0ZDRiMTNjNDU0MGI4ZWRkMTY0ODM0MWQ1ZDIvdGFibGVyYW5nZTo1NmEwMDRkNGIxM2M0NTQwYjhlZGQxNjQ4MzQxZDVkMl8yLTAtMS0xLTA_e0b496b4-eb84-4286-b5cf-bb07f0cda4fa">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NTZhMDA0ZDRiMTNjNDU0MGI4ZWRkMTY0ODM0MWQ1ZDIvdGFibGVyYW5nZTo1NmEwMDRkNGIxM2M0NTQwYjhlZGQxNjQ4MzQxZDVkMl8yLTItMS0xLTA_2a2734e8-8b8b-4926-94ab-24db7a485012">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8zMzQ_26842337-6919-4023-9683-90d472165c1e">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8zMzg_f162d315-2b94-43dd-9391-b688b5afdbcb">550-7500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl82MzU_c9f3d7f3-0cfa-43da-aeff-b53e900467f1">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl83MjQ_f18980bd-73e1-42e4-a648-3fae5e5b001a">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl84MTQ_9522b1a1-65f8-4821-a046-d22f18f9b677">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl85MjA_df408752-7ccf-4e51-a095-12dd50867012">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NzAyNjlkOTAwNTA3NDliM2E3OWVkNjIxYzQ1OWVmNzAvdGFibGVyYW5nZTo3MDI2OWQ5MDA1MDc0OWIzYTc5ZWQ2MjFjNDU5ZWY3MF8xLTAtMS0xLTA_710424b0-d7de-46ec-997c-d79cfa81a561">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NzAyNjlkOTAwNTA3NDliM2E3OWVkNjIxYzQ1OWVmNzAvdGFibGVyYW5nZTo3MDI2OWQ5MDA1MDc0OWIzYTc5ZWQ2MjFjNDU5ZWY3MF8xLTEtMS0xLTA_8aca0a46-790e-48da-8e6b-b6f4c401480c">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGFibGU6NzAyNjlkOTAwNTA3NDliM2E3OWVkNjIxYzQ1OWVmNzAvdGFibGVyYW5nZTo3MDI2OWQ5MDA1MDc0OWIzYTc5ZWQ2MjFjNDU5ZWY3MF8xLTItMS0xLTA_3f55a870-228a-4269-bdb2-5ae12bff644a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218"
      id="id3VybDovL2RvY3MudjEvZG9jOjJiYmQ5YTFiMWYxNTQyNDg4YTQ5NThkNzdhOGQ4ZWZlL3NlYzoyYmJkOWExYjFmMTU0MjQ4OGE0OTU4ZDc3YThkOGVmZV8xL2ZyYWc6NGM3NGMyODEyNzY4NDlkMTk4NWEyYTBlYjdiZDg5ZjYvdGV4dHJlZ2lvbjo0Yzc0YzI4MTI3Njg0OWQxOTg1YTJhMGViN2JkODlmNl8xMzU0_6860a5f1-1ed8-4a0c-a13c-751468f641ce">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139635426137320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Dec. 18, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 18,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3911 Sorrento Valley Boulevard, Suite 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MS2\W<.CGVKX SU=*F?>&/8<6_T88_@502P,$%     @ _$2548.II0/4 0
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M5_J^OH:&#Q+/6S*G>_P9:C&H-UO58UB7I6J//X7W*+F?&^[_$L4/4$L#!!0
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #\1)51!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M /Q$E5'8]L4Y[P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( /Q$E5&97)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ _$2541YN
M U!.!   4A   !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( /Q$E5&#J:4#U $  #(&   -
M  "  9(,  !X;"]S='EL97,N>&UL4$L! A0#%     @ _$2549>*NQS
M$P(   L              ( !D0X  %]R96QS+RYR96QS4$L! A0#%     @
M_$2541E%%?4W 0  )P(   \              ( !>@\  'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( /Q$E5$D'INBK0   /@!   :              "
M =X0  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /Q$
ME5%ED'F2&0$  ,\#   3              "  <,1  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(   T3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lgnd-20201218.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="lgnd-20201218.htm">lgnd-20201218.htm</File>
    <File>exhibit991_201221gskagreem.htm</File>
    <File>lgnd-20201218.xsd</File>
    <File>lgnd-20201218_cal.xml</File>
    <File>lgnd-20201218_def.xml</File>
    <File>lgnd-20201218_lab.xml</File>
    <File>lgnd-20201218_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20201218.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20201218_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20201218_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20201218.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20201218_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20201218_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20201218.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20201218",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20201218.htm",
      "contextRef": "i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.ligand.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20201218.htm",
      "contextRef": "i6598a0240f8e4d50aec47ebe818df25b_D20201218-20201218",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000886163-20-000141-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-20-000141-xbrl.zip
M4$L#!!0    ( /Q$E5''MD5QEQ(  !=%   >    97AH:6)I=#DY,5\R,#$R
M,C%G<VMA9W)E96TN:'1M[5QK<]PVLOU^?P56WNO853.21M9;7E<IDN/UKF-K
M8VU<]U,*)#$SB$B" <@9S?[Z/=T 2,[+\<W&L3:55$661R30Z#[=?;H;\O,_
M7;^[NOV_FY=B6A>YN/GGUV]>7XF=X=[>AV=7>WO7M]?BK[??OA&'N_LC<6ME
MZ72M32GSO;V7;W?$SK2NJ_.]O?E\OCM_MFOL9._VNSU:ZG O-\:IW:S.=EX\
MIT_P5<GLQ?\\_]-P**Y-VA2JK$5JE:Q5)AJGRXGXD"EW)X;#\-25J1963Z:U
M.-@_V!<?C+W3,^E_7NLZ5R_B.L_W_-^?[_$FSQ.3+5X\S_1,Z.PO.WHT'F7)
MP<GQB<Q.#@]&ZO0X?79TIIX=/#L[/C@^?O;#"$+NX7'_CJL7N?K+3J'+X531
M_N>'1U5],==9/3T?[>__[PX_]^+YV)0U-K-XV7_KUUA;J5;W]5"7&20]'YU6
M]<[65_F++B9"YC4$+^1$_; _VOVQFNP(9].UC_SZ0<KCL^K^HI!V L$34]>F
M.">Y9\K6.I7Y4.9Z4IZS,/['\4AGQ]7]1@WXM6I3G1]C(7[3+_)CXVH]7GST
M($NG]Z^ET("RX:WX\]3DQIX_VN?_+N@GP[$L=+XX_^I6%\J)MVHNOC.%++\:
M.$!PZ)358_^@T_]2YZ,1A.._SKTB3K!.KDL5S3<Z()N]T1-99H+^?_7^[^(E
MB2)>Y2:1.:"6YS(Q5A*\^9$W&L(Z)2XG5BG&ZAL%3<H) ?5U"BN4CQ^='HQ.
M+IRXUBXU^.%"W*IT6N(\DX6HC;B%_E0-^1M+GY$1Z%EC,V7=!L,_!%T>1%WR
MBN>ZQF[IDG8/5[4[&G7:?65-4PGMA(*0.LD5Z<&J5.F9@EY%4XTMR5O)!2O5
MC,6?3P0DS*/B*U/C!QJJPJ?*U:94\6G'#XP5SH'WL _6_O/HZ'#W:&F%6BN+
MF&+- EZDU7^LZ66P_]:P?7_Y5ER_?OGJG7AR#3T6"5![,!IP3'PJ&(.C"Q'4
M?S.5MI"I:MCCG7A=IL96A&LHY,G;R_?7E_]X_.CH%"^\>GO]-)[^\YYK#3!\
M+IBJ-$V90K#:9'(AI$C7O# /7BA;+TQ4/5>J%!IH<$WB=*:E70R"2PZ\>^?R
MWKPO=#W].^TKGL#?GQ)8<N_":M6!FU+_U"BA[BN*E=A/E\(5,@<&3:[2AF \
MQ9L5*]:)FAV;(D%-2;& 5? G<&H!7EVZ72%NIW""Y0/-@5&!!7)HB=8+4HBL
M#1_U4OC0E#  /#Y3!M%S ]<JISK1M;'L U*X2J5ZK%.!E11;/5\,9P!NQC8/
M\DL;9(8O0@D2BL0&93\P00HEG2+9__].\>!\:3/FR. '^Q<? "BK!*N\RNG4
MA$%$&5N7\*XY@ /-3GQJJ)9<"B8M*EDN@,P[Q7G$/PVX%@F1H\;!1*69!0S#
M*ID<\+[P4B=U)KZ5=2V^,6IJ!^+&*L=F9AM?O7M'1O6^O/OXT>AX_T($F1E/
MG1N,"?] ZUBE=;Y@(8!9 E6(!*XFI_= 0A252:[=U/M4=()P7C?5E?/' $>!
M?: 5*(5RE)".U@0"TU0Y(*ZQ'48167F]SFO&QM+CVHK,-I-AA^M2J<S% Y'2
MIE@8\8E3@YF4,"$L,)6UF! A).1+\IX":UI3$&A9GUY45GU-^J#<P!&?9)Q*
M2C$"G\,[%J1(U[#8XR8G%1%]A,?R00VYLR/=A)/U;<;>EB-A60@.Y))G!1=F
M=\<Q"^EYL"A4IE/@C$['-OZ]^\X5T&=Q<*@.AFPCZ!KFB0,LJ3QM:HJ80Y7U
MH$?+3%5>H0!H(]S&0#;XB.HI6L_EPGD$D6>/I2-R1Y8L#/ZNQN0GL.BR)_[-
M3$O0.N1'-1#O5:F!W^^1<3JW'(CO%,*B3:<#.BYB8U"#][+5!%(8 $>X!78O
M7 !217 ;][R$TX J)9$C[U"R8"1FB,MI0/:* R&Q3"P>"Z%I"KO@?/@TD0GR
M2=V'NS\V$BHK-B)9 LMS*!'NY8E7Q<8BEZV@4697KH&>+%F,O6Y3>M@*\X^7
M-%\"L/]$P<7Q"!JV!:=+^LLGD(Q!#*)LJD]EKP!'>"TU39YU[V59J)HCQ/T>
M5DV0F#E6^9>*0MD4Q%?_R\NVSG\'>*IL5Z-'5* A4U3;W0MX< M![H1<.MLJ
M9::UX85PD]R3;4IYA$F/C'4]LNLQX^E.@063!;O-?PL#WPRDOL(2!9VY"JF(
MBQMRG\(X( *:Q)OL*I)"C68U>A-0-F6'*X)I!]Z15RK2GD;)I#T"F.(1CH..
M=Z00O$#4PR.OWUX/.9;0*ZYN,LT,+N98,I2Z3_/&D96#SY-$$?(P:]A%PUP]
M<OFQ$].JX\92#NU#>@N,^^CI':2W;3U%U3B9KL.J0ZM,?VHT031P9H3\R\KJ
MG,N@ ?L8%-!J8HFDD"81W1)J,C&+B5&.0<N'=$V%+%#[V-L3 4K;'(G7(?W?
ME^<WUYN7B6GJJ.9>/^,&L8K2[R^H#GYKA[WM:JM-!]#D16E#K!\0*B1@M*"
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MB% ^]J4+D.\,^=D2*_=]Z39.P\4=#NSG:J'SY6>>1*)"4>K'5+T&-H4KM^[
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M_;6:,U74DVW;KLQYGT6E*F6778KN4N:5A_%9!0J@6]G&DHQ5>5D]#*+3[X#
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MTR1A&0^97S$I[W6[EGU;;M%MANEU.^YUV/@5-Z8+^#/*QN'._P-02P,$%
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MLG[_E-U^/SJ)G6%[R"\&/P!02P,$%     @ _42549.C< F$ 0  S@(  !4
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M@/"0%#-/\BP)6)CP;,1$)$2>4#_V1<PI\#C-,OKW@FA*+L;R?/ /4$L#!!0
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M2G:APTG [5GWT&Z#T\%DVY[0NF)W6/7LR<M_KM),PK&O92D#3D 2(W,W#Q'
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MMUO0=HA?M6=0:[([=@YJ/Z?[ZJZG;1__T'/RL=+S9*%0#&@(=<W NGDG0DB
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M3E(1DP7<+G%DV6BAB$C)6FVB<F**^O'['HQ#8\9=SHG$G1<BQVU["<W#N?B
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M4$L! A0#%     @ _42542#U!)^, @  ?@D  !$              ( !#2@
M &QG;F0M,C R,#$R,3@N>'-D4$L! A0#%     @ _42549.C< F$ 0  S@(
M !4              ( !R"H  &QG;F0M,C R,#$R,3A?8V%L+GAM;%!+ 0(4
M Q0    ( /U$E5$_8 \;"@(  '<&   5              "  7\L  !L9VYD
M+3(P,C Q,C$X7V1E9BYX;6Q02P$"% ,4    " #]1)51W+^8I8$*  #.7@
M%0              @ &\+@  ;&=N9"TR,#(P,3(Q.%]L86(N>&UL4$L! A0#
M%     @ _4254<J=%6FO!@  ;C$  !4              ( !<#D  &QG;F0M
F,C R,#$R,3A?<')E+GAM;%!+!08     !P ' -8!  !20      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
